Law ❯ Litigation ❯ Class Action ❯ Securities Fraud

Corporate Governance

Gartner Investors Urged to Seek Lead-Plaintiff Role as May 18 Deadline Nears

Plaintiffs say Gartner overstated contract value growth, downplaying seasonality risk.

Stories older than 24h

Class Action Filed Against Atara Biotherapeutics Over Alleged Misstatements on FDA Setbacks

Gossamer Bio Investors Face June 1 Deadline in Securities Class Action

Law Firm Seeks Medpace Investors to Lead Securities Class Action

Law Firms Press Soleno Investors to Seek Lead Role in Securities Suit by May 5

Aldeyra Therapeutics Sued in Securities Class Action Over Reproxalap Trial Disclosures

Super Micro Faces Shareholder Lawsuits After DOJ Alleges $2.5 Billion China Export Scheme

Law Firm Seeks Nektar Investors to Lead Securities Suit Over REZOLVE‑AA Trial Claims

Richtech Investors Face April 3 Deadline to Lead Lawsuits Over Disputed Microsoft Tie

Richtech Robotics Investors Urged to Act as April 3 Lead‑Plaintiff Deadline Nears

Ardent Health Investors Urged to Seek Lead Role Before March 9 in Securities Class Action

BellRing Faces Securities Class Action in SDNY Over Alleged Misstatements on Demand

Oracle Sued by Bondholders Over Alleged AI Debt Disclosure Lapses

Sprouts Investors Face Jan. 26 Deadline to Seek Lead Role in Securities Class Action

Ardent Health Hit With Securities Class Action Over Receivables and Reserve Disclosures

Baxter Investors Face Dec. 15 Lead-Plaintiff Deadline in Novum Pump Securities Suit

Investor Firms Press Sprouts Class Action as Lead‑Plaintiff Deadline Nears

Perrigo Faces Securities Class Action Over Nestlé Infant-Formula Unit After Guidance Cut

Plaintiffs’ Firms Step Up Marex Class-Action Push Before Dec. 8 Lead-Plaintiff Cutoff

LifeMD Securities Suit Intensifies as Lead Plaintiff Deadline Nears